Overview
Biomarkers are objectively measurable indicators of normal biological processes, pathogenic processes, or responses to an intervention. They encompass molecular species such as proteins, enzymes, hormones, metabolites, nucleic acids, and epigenetic marks, as well as cellular, imaging, and physiological measurements, detectable in tissue or in accessible fluids including blood, plasma, urine, and saliva. Functionally they are classified as diagnostic, prognostic, predictive, pharmacodynamic, monitoring, and susceptibility or risk biomarkers, each serving a distinct decision in clinical care or research. Rigorous biomarker development demands analytical validation, demonstration of clinical validity and utility, and attention to specificity, reproducibility, and confounding before translation. In oncology and genetics, biomarkers enable earlier detection, molecular subclassification, treatment selection, and surveillance of disease burden and resistance. Emerging classes such as circulating and epigenetic markers and microRNAs are expanding minimally invasive testing. Peer-reviewed research published in this area examines epigenetic biomarkers and long non-coding RNAs in head and neck cancer, plasma microRNA expression and PD-L1 status in melanoma, molecular and newborn microRNA biomarkers, high-throughput platforms for cancer biomarker development, immunoglobulin-based markers of female infertility, and biomarker readouts in cell-line and animal models, reflecting the discipline's focus on Cancer Genetics And Biomarkers.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Long Non-Coding RNAs Emerging as Potential Epigenetic Biomarkers for Tobacco and/or Alcohol-Induced Head and Neck Cancer
Molecular Biomarkers: A Brief Review
Developing Cellular & Molecular Biomarkers for Anti-Inflammatory Activities of Probiotic Bacteria in Fermented Foods
Dynamic MicroRNA-Expression in Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
High-Throughput Complex Disease Modeling for Ethical Drug Discovery: Clinical Relevance of a NAM Platform for Cancer Biomarker Development
Newborns' MicroRNA Expression as Potential Biomarkers for Disease Diagnosis
Effect of the Biofield Energy Treated Proprietary Test Formulation for Sleep Biomarkers in the Unpredictable Chronic Stress (UCS) Animal Model
Preconception Immunoglobulins and Complements as Potential Biomarkers in Unexplained Female Infertility in Saudi Arabia
Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
How this research is being cited
The 12 articles above have been cited 15 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Human Gene
-
2026 · Gene Reports
-
Maria Constantin et al. · 2024 · Frontiers in Oncology
-
2024 · Biomedical Research and Therapy
-
2024 ·
-
2023 · Medical Oncology
-
S. Kurevlev et al. · 2023 · Head and Neck Tumors (HNT)
-
2023 · Medical Oncology
A sample of recent works citing this journal's research on Biomarkers, linking to each citing work.